Drug Profile
Research programme: amyotrophic lateral sclerosis therapies - Metabolon
Latest Information Update: 28 Aug 2018
Price :
$50
*
At a glance
- Originator Metabolon
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Amyotrophic lateral sclerosis